{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:06:50Z","timestamp":1795043210546,"version":"4.10.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"university hospital of reims"},{"DOI":"10.13039\/501100016399","name":"Universit\u00e9 de Reims Champagne-Ardenne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cough and sputum are major symptoms in cystic fibrosis (CF) that contribute to the impairment of quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective single centre cross-sectional pilot study aimed to evaluate the results of a self-administered questionnaire assessing cough and sputum symptoms (2 domains), and their impact (2 domains) on daily activities in the previous week, named the Cough and Sputum Assessment Questionnaire (CASA-Q) in CF adult patients at stable state, and to analyse associations with clinical, functional, microbiological, radiological data, and two quality of life scales: the Cystic Fibrosis Questionnaire Revised (CFQ-R) and the Saint George Respiratory Questionnaire (SGRQ).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty-eight patients were included in this analysis (69% men; median age of 27.8\u2009\n                      <jats:underline>\u00b1<\/jats:underline>\n                      \u20098.1 years; median body mass index of 21.8\u2009\n                      <jats:underline>+<\/jats:underline>\n                      \u20093.3\u00a0kg\/m\u00b2; mean FEV\n                      <jats:sub>1<\/jats:sub>\n                      of 64\u2009\n                      <jats:underline>\u00b1<\/jats:underline>\n                      \u200930% of the predicted value). The mean values of the CASA-Q domains were 58\u2009\n                      <jats:underline>\u00b1<\/jats:underline>\n                      \u200923 for cough symptoms, 77\u2009\n                      <jats:underline>\u00b1<\/jats:underline>\n                      \u200924 for cough impact, 62\u2009\n                      <jats:underline>\u00b1<\/jats:underline>\n                      \u200925 for sputum symptoms and 84\u2009\n                      <jats:underline>\u00b1<\/jats:underline>\n                      \u200921 for sputum impact. Impairment in CASA-Q cough and sputum domains was associated with dyspnea mMRC scale (p\u2009&lt;\u20090.005 for all 4 domains of CASA-Q) and exacerbations in the previous year (p\u2009&lt;\u20090.05 for CASA-Q symptoms domains). We also found correlations between all domains of the CASA-Q and quality of life questionnaires including SGRQ (p\u2009&lt;\u20090.001) and to a lesser extend CFQ-R. We identified a clinical phenotype (female gender, \u0394F508 heterozygous mutation, dyspnea mMRC scale) associated with an impairment of CASA-Q score and quality of life using a 2-step cluster analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CASA-Q allows the assessment of cough and sputum in CF adult patients and is associated with quality of life impairment. This simple easy-to-use tool could be used in routine clinical practice and in clinical studies to assess cough and sputum in CF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>The study was registered on ClinicalTrials.gov (NCT02924818, first posted on 5th October 2016).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02701-3","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:05:25Z","timestamp":1700571925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current cough and sputum assessed by the cough and sputum assessment-questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Lucie","family":"Charon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Launois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne-Marie","family":"Perotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ravoninjatovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Mulette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Ancel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Guillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00eblle","family":"Muggeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rian","family":"Dormoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Griffon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Carr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lebargy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Desl\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"issue":"1","key":"2701_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrg3849","volume":"16","author":"GR Cutting","year":"2015","unstructured":"Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet Janv. 2015;16(1):45\u201356.","journal-title":"Nat Rev Genet Janv"},{"issue":"9678","key":"2701_CR2","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","volume":"373","author":"BP O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan BP, Freedman SD. Cystic fibrosis. The Lancet mai. 2009;373(9678):1891\u2013904.","journal-title":"The Lancet mai"},{"issue":"4","key":"2701_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.pcl.2016.04.001","volume":"63","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Fink AK. Background and epidemiology. Pediatr Clin North Am ao\u00fbt. 2016;63(4):567\u201384.","journal-title":"Pediatr Clin North Am ao\u00fbt"},{"key":"2701_CR4","unstructured":"Wenninger K, Aussage P, Wahn U, Staab D. The revised German cystic fibrosis questionnaire: validation of a disease-specific health-related quality of life instrument.:11."},{"key":"2701_CR5","unstructured":"Padilla A, Olveira G, Olveira C, Dorado A, Plata AJ, Gaspar I et al. Validity and reliability of the St George\u2019s respiratory questionnaire in Adults With Cystic Fibrosis.:7."},{"issue":"11","key":"2701_CR6","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.rmed.2008.06.009","volume":"102","author":"B Crawford","year":"2008","unstructured":"Crawford B, Monz B, Hohlfeld J, Roche N, Rubin B, Magnussen H, et al. Development and validation of a cough and sputum assessment questionnaire. Respiratory Med nov. 2008;102(11):1545\u201355.","journal-title":"Respiratory Med nov"},{"issue":"6","key":"2701_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/cea.13359","volume":"49","author":"K Alagha","year":"2019","unstructured":"Alagha K, Bourdin A, Vernisse C, Garulli C, Tummino C, Charriot J, et al. Goblet cell hyperplasia as a feature of neutrophilic Asthma. Clin Exp Allergy juin. 2019;49(6):781\u20138.","journal-title":"Clin Exp Allergy juin"},{"issue":"6","key":"2701_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5539\/gjhs.v5n6p131","volume":"5","author":"K Gries","year":"2013","unstructured":"Gries K, Esser D, Wiklund I. Content validity of CASA-Q Cough domains and UCSD-SOBQ for Use in patients with Idiopathic Pulmonary Fibrosis. Global J Health Sci. 2013;5(6):11.","journal-title":"Global J Health Sci"},{"issue":"3","key":"2701_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.resinv.2019.01.002","volume":"57","author":"T Suzuki","year":"2019","unstructured":"Suzuki T, Shirai T, Hirai K, Tanaka Y, Watanabe H, Endo Y, et al. Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary Tuberculosis. Respiratory Invest mai. 2019;57(3):252\u20139.","journal-title":"Respiratory Invest mai"},{"key":"2701_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.physio.2019.11.001","volume":"107","author":"M San Miguel-Pagola","year":"2020","unstructured":"San Miguel-Pagola M, Reychler G, Cebri\u00e0 i Iranzo MA, G\u00f3mez-Romero M, D\u00edaz-Guti\u00e9rrez F, Herrero-Cortina B. Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial. Physiotherapy juin. 2020;107:243\u201351.","journal-title":"Physiotherapy juin"},{"issue":"1","key":"2701_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","volume":"2","author":"TWR Lee","year":"2003","unstructured":"Lee TWR, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa Infection in cystic fibrosis patients. J Cyst Fibros mars. 2003;2(1):29\u201334.","journal-title":"J Cyst Fibros mars"},{"issue":"3","key":"2701_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell DM, Bankier AA, MacMahon H, McLoud TC, M\u00fcller NL, Remy J. Fleischner Society: Glossary of terms for thoracic imaging. Radiol mars. 2008;246(3):697\u2013722.","journal-title":"Radiol mars"},{"issue":"3","key":"2701_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1148\/radiol.2253011575","volume":"225","author":"GC Ooi","year":"2002","unstructured":"Ooi GC, Khong PL, Chan-Yeung M, Ho JCM, Chan PKS, Lee JCK, et al. High-resolution CT quantification of Bronchiectasis: clinical and functional correlation. Radiol d\u00e9c. 2002;225(3):663\u201372.","journal-title":"Radiol d\u00e9c"},{"issue":"4","key":"2701_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.rmed.2009.10.026","volume":"104","author":"BU Monz","year":"2010","unstructured":"Monz BU, Sachs P, McDonald J, Crawford B, Nivens MC, Tetzlaff K. Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and Chronic Bronchitis. Respiratory Med avr. 2010;104(4):534\u201341.","journal-title":"Respiratory Med avr"},{"issue":"4","key":"2701_CR15","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","volume":"128","author":"AL Quittner","year":"2005","unstructured":"Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of the cystic fibrosis questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest oct. 2005;128(4):2347\u201354.","journal-title":"Chest oct"},{"key":"2701_CR16","volume-title":"Multivariate Data Analysis","author":"JF Hair","year":"2014","unstructured":"Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate Data Analysis. 7th ed. Harlow. Harlow: Pearson Education Limited; 2014.","edition":"7"},{"key":"2701_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/apa.1989.78.s363.52","volume":"78","author":"DM Geddes","year":"1989","unstructured":"Geddes DM, Shiner R. Cystic fibrosis-from lung damage to symptoms. Acta Paediatr Nov. 1989;78:52\u20137.","journal-title":"Acta Paediatr Nov"},{"issue":"2","key":"2701_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpsychores.2010.06.005","volume":"70","author":"GS Sawicki","year":"2011","unstructured":"Sawicki GS, Sellers DE, Robinson WM. Associations between Illness perceptions and health-related quality of life in adults with cystic fibrosis. J Psychosom Res f\u00e9vr. 2011;70(2):161\u20137.","journal-title":"J Psychosom Res f\u00e9vr"},{"issue":"4","key":"2701_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcf.2009.04.003","volume":"8","author":"CH Goss","year":"2009","unstructured":"Goss CH, Edwards TC, Ramsey BW, Aitken ML, Patrick DL. Patient-reported respiratory symptoms in cystic fibrosis. J Cyst Fibros Juill. 2009;8(4):245\u201352.","journal-title":"J Cyst Fibros Juill"},{"issue":"4","key":"2701_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1513\/pats.200703-039BR","volume":"4","author":"CH Goss","year":"2007","unstructured":"Goss CH, Quittner AL. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 1 ao\u00fbt. 2007;4(4):378\u201386.","journal-title":"Proc Am Thorac Soc 1 ao\u00fbt"},{"key":"2701_CR21","doi-asserted-by":"crossref","unstructured":"Faruqi S, Shiferaw D, Morice AH. Effect of Ivacaftor on Objective and Subjective Measures of Cough in Patients with Cystic Fibrosis. TORMJ. 30 d\u00e9c 2016;10(1):105\u20138.","DOI":"10.2174\/1874306401610010105"},{"key":"2701_CR22","doi-asserted-by":"crossref","unstructured":"Niehammer U, Steindor M, Stra\u00dfburg S, Sutharsan S, Taube C, Welsner M, et al. Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation. Health Qual Life Outcomes. oct 2022;6(1):141.","DOI":"10.1186\/s12955-022-02053-2"},{"issue":"1","key":"2701_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/resp.13125","volume":"23","author":"KB Frayman","year":"2018","unstructured":"Frayman KB, Kazmerski TM, Sawyer SM. A systematic review of the prevalence and impact of urinary incontinence in cystic fibrosis. Respirol janv. 2018;23(1):46\u201354.","journal-title":"Respirol janv"},{"issue":"5","key":"2701_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0022-3476(05)82653-8","volume":"116","author":"E Kerem","year":"1990","unstructured":"Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr Mai. 1990;116(5):714\u20139.","journal-title":"J Pediatr Mai"},{"key":"2701_CR25","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.2147\/COPD.S106883","volume":"Volume 11","author":"G Deslee","year":"2016","unstructured":"Deslee G, Burgel PR, Escamilla R, Chanez P, Court-Fortune I, Nesme-Meyer P, et al. Impact of current cough on health-related quality of life in patients with COPD. COPD sept. 2016;Volume 11:2091\u20137.","journal-title":"COPD sept"},{"issue":"7","key":"2701_CR26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s11136-011-0091-5","volume":"21","author":"AL Quittner","year":"2012","unstructured":"Quittner AL, Sawicki GS, McMullen A, Rasouliyan L, Pasta DJ, Yegin A, et al. Erratum to: psychometric evaluation of the cystic fibrosis questionnaire-revised in a national, US sample. Qual Life Res sept. 2012;21(7):1279\u201390.","journal-title":"Qual Life Res sept"},{"key":"2701_CR27","doi-asserted-by":"crossref","unstructured":"Ward N, Stiller K, Rowe H, Holland AE. The psychometric properties of the Leicester Cough Questionnaire and respiratory symptoms in CF tool in cystic fibrosis: a preliminary study. 2016;8.","DOI":"10.1016\/j.jcf.2016.11.011"},{"key":"2701_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2147\/COPD.S219480","volume":"15","author":"P Rebelo","year":"2020","unstructured":"Rebelo P, Oliveira A, Paix\u00e3o C, Valente C, Andrade L, Marques A. Minimal clinically important differences for patient-reported outcome measures of Cough and Sputum in patients with COPD. COPD janv. 2020;15:201\u201312.","journal-title":"COPD janv"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02701-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:10:04Z","timestamp":1700572204000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02701-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2701"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02701-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3052609\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]},"assertion":[{"value":"12 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patients were prospectively recruited from the University Hospital of Reims - Department of Respiratory Diseases between November 2016 and December 2019. Patients were included in the RINNOPARI study (Recherche et INNOvation en PAthologie Respiratoire Inflammatoire). This study was approved by the Ethics Committee of Dijon EST I on 31rd October 2016(N\u00b02016-A00242-49) and by the French National Agency for Medicines and Health Products (ANSM) on 25th April 2016. The protocol was registered on ClinicalTrials.gov (NCT02924818, first posted on 5th October 2016). Each patient signed a written informed consent form. All methods including recruitment, data collection and analysis have been performed in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Each patient signed a written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient agreement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"457"}}